搜索临床试验以:Palpable Node-Positive HR /HER2
总计26575个结果
-
Georgetown UniversityMedstar Health Research Institute; Breast Cancer Research Foundation; Georgetown-Howard Universities...终止
-
Memorial Sloan Kettering Cancer CenterPuma Biotechnology, Inc.主动,不招人
-
The Netherlands Cancer InstituteRoche Pharma AG; Borstkanker Onderzoek Groep主动,不招人
-
First Affiliated Hospital of Harbin Medical UniversityShanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd未知
-
SOLTI Breast Cancer Research Group终止
-
Yi MiaoNanjing Abingen Biotech Co. Ltd未知
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
Guangdong Academy of Medical SciencesGuangzhou First People's Hospital; Guangzhou General Hospital of Guangzhou Military Command; Chinese...未知
-
Latin American Cooperative Oncology GroupRoche Pharma AG; Oncoclínicas尚未招聘
-
Fudan UniversityChongqing University Cancer Hospital; Sun Yat-sen University; Peking University Cancer Hospital... 和其他合作者招聘中
-
M.D. Anderson Cancer CenterZymeworks BC Inc.主动,不招人
-
Spanish Breast Cancer Research GroupAstraZeneca终止
-
Dana-Farber Cancer InstituteNovartis完全的
-
Beijing Chest HospitalJiangsu HengRui Medicine Co., Ltd.尚未招聘HER2突变型非小细胞肺癌
-
Olema Pharmaceuticals, Inc.Novartis招聘中
-
Memorial Sloan Kettering Cancer CenterSeagen Inc.招聘中
-
UNC Lineberger Comprehensive Cancer CenterIncyte Corporation撤销乳腺癌 | 乳腺肿瘤 | 三阴性乳腺癌 | HER2阳性乳腺癌
-
Filipa Lynce, MDAstraZeneca; Daiichi Sankyo, Inc.招聘中
-
Jules Bordet InstituteRoche Pharma AG主动,不招人
-
Novartis Pharmaceuticals完全的
-
Borstkanker Onderzoek GroepRoche Pharma AG; BOOG Study Center主动,不招人
-
GlaxoSmithKline终止肿瘤美国, 大韩民国, 加拿大, 西班牙, 澳大利亚, 英国, 法国
-
University of California, IrvineNational Cancer Institute (NCI); National Institutes of Health (NIH)完全的乳腺癌 | HER2阳性乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIIC期乳腺癌 | 复发性乳腺癌 | HER2 阴性乳腺癌美国
-
University of NebraskaNational Cancer Institute (NCI)主动,不招人HER2阳性乳腺癌 | I 期乳腺癌 AJCC v7 | IA 期乳腺癌 AJCC v7 | IB 期乳腺癌 AJCC v7 | II 期乳腺癌 AJCC v6 和 v7 | IIA 期乳腺癌 AJCC v6 和 v7 | IIB 期乳腺癌 AJCC v6 和 v7美国
-
Novartis Pharmaceuticals完全的